| Literature DB >> 33725478 |
Cristina C Clement1, Padma P Nanaware2, Takahiro Yamazaki1, Maria Pia Negroni2, Karthik Ramesh3, Kateryna Morozova1, Sangeetha Thangaswamy1, Austin Graves4, Hei Jung Kim5, Tsai Wanxia Li6, Marco Vigano'7, Rajesh K Soni8, Massimo Gadina6, Harley Y Tse9, Lorenzo Galluzzi10, Paul A Roche5, Lisa K Denzin4, Lawrence J Stern11, Laura Santambrogio12.
Abstract
Hyperglycemia and hyperlipidemia are often observed in individuals with type II diabetes (T2D) and related mouse models. One dysmetabolic biochemical consequence is the non-enzymatic reaction between sugars, lipids, and proteins, favoring protein glycation, glycoxidation, and lipoxidation. Here, we identified oxidative alterations in key components of the major histocompatibility complex (MHC) class II molecule antigen processing and presentation machinery in vivo under conditions of hyperglycemia-induced metabolic stress. These modifications were linked to epitope-specific changes in endosomal processing efficiency, MHC class II-peptide binding, and DM editing activity. Moreover, we observed some quantitative and qualitative changes in the MHC class II immunopeptidome of Ob/Ob mice on a high-fat diet compared with controls, including changes in the presentation of an apolipoprotein B100 peptide associated previously with T2D and metabolic syndrome-related clinical complications. These findings highlight a link between glycation reactions and altered MHC class II antigen presentation that may contribute to T2D complications.Entities:
Keywords: CD4(+) T cells; MHC class II; advanced glycation end products; antigen processing and presentation; dendritic cells; diabetes; hyperinsulinemia; obesity; oxidative posttranslational modifications
Mesh:
Substances:
Year: 2021 PMID: 33725478 PMCID: PMC8046741 DOI: 10.1016/j.immuni.2021.02.019
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745